Loop Industries, Inc. 10-K

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Loop Industries, Inc. February 29, 2024 Index to the Consolidated Financial Statements Contents Page(s) Report of Independent Registered Public Accounting Firm (PCAOB ID: 271 ) F-1 Consolidated balance sheets as at February 29, 2024 and February 28, 2023 F-2 Consolidated statements of operations and comprehensive loss for the years ended February 29, 2024 and February 28, 2023 F-3 Consolidated statements of changes in stockholders’ equity for the years ended February 29, 2024 and February 28, 2023 F-4 Consolidated statements of cash flows for the years ended February 29, 2024 and February 28, 2023 F-6 Notes to the consolidated financial statements F-7 39 Table of Contents Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of Loop Industries, Inc. Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Loop Industries, Inc. and its subsidiaries (together, the Company) as of February 29, 2024 and February 28, 2023, and the related consolidated statements of operations and comprehensive loss, changes in stockholders’ equity and cash flows for the years then ended, including the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of February 29, 2024 and February 28, 2023, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. Substantial Doubt About the Company’s Ability to Continue as a Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred net losses and negative cash flow from operating and investing activities since its inception that and has stated that these events or conditions indicate that a material uncertainty exists that raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. This matter is also described in the Critical Audit Matters section of our report. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. Critical Audit Matters The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates. Going Concern Assessment As described in note 1 to the consolidated financial statements, the Company’s consolidated financial statements have been prepared on a going concern basis. For the year ended February 29, 2024, the Company incurred a net loss of $21.1 million and the net cash flows used from operating activities was $18.0 million. As of February 29, 2024, the Company’s available liquidity was $9.5 million, consisting of cash and cash equivalents of $6.9 million and an undrawn senior loan facility from a Canadian bank of $2.6 million. Management estimates that current available liquidity and forecasted net cash flows will not be sufficient to meet the Company’s obligations, commitments and budgeted expenditures for the next twelve months from the consolidated financial statements issuance date. Management evaluates the Company’s liquidity to determine if there is substantial doubt about the Company’s ability to continue as a going concern. In preparing this going concern assessment, management applies significant judgment in estimating future cash flow requirements of the Company based on budgets and forecasts, which includes developing assumptions related to the estimation of amount and timing of future cash outflows and inflows. This matter is also described in the Substantial Doubt About the Company’s Ability to Continue as a Going Concern section of our report. The principal considerations for our determination that performing procedures relating to the going concern assessment is a critical audit matter are the significant judgment by management in estimating future cash flow requirements of the Company based on budgets and forecasts, which includes developing assumptions related to the estimation of amount and timing of future cash outflows and inflows. This in turn led to a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating audit evidence related to management’s estimation of amount and timing of future cash outflows and inflows. Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, evaluating management’s assessment of whether the Company has sufficient cash resources for the next 12 months from the date of the issuance of the consolidated financial statements. This included (i) testing the completeness and accuracy of the underlying data used in management’s estimation of future cash flow requirements; and (ii) evaluating the reasonableness of management’s assumptions related to the estimation of the amount and timing of future cash outflows and inflows. The evaluation of these assumptions considered (i) management’s historical accuracy in forecasting cash flows and settling budgets; and (ii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Additionally, these procedures included evaluating the sufficiency of the Company’s going concern disclosure. /s/ PricewaterhouseCoopers LLP Montréal, Canada May 29, 2024 We have served as the Company’s auditor since 2017. F-1 Table of Contents Loop Industries, Inc. Consolidated Balance Sheets (in thousands of U.S. dollars, except per share data) As at February 29, 2024 February 28, 2023 Assets Current assets Cash and cash equivalents $ 6,958 $ 29,591 Restricted cash (Note 11) - 1,000 Sales tax, tax credits and other receivables (Note 3) 351 1,075 Inventories (Note 4) 102 727 Deposits on machinery and equipment (Note 5) - 3,395 Prepaid expenses and other deposits (Note 6) 577 636 Total current assets 7,988 36,424 Investment in joint venture (Note 12) 381 381 Property, plant and equipment, net (Note 7) 10,636 2,545 Intangible assets, net (Note 8) 1,548 1,210 Total assets $ 20,553 $ 40,560 Liabilities and Stockholders' Equity Current liabilities Accounts payable and accrued liabilities (Note 10) $ 2,321 $ 2,510 Customer deposits (Note 11) - 1,012 Current portion of long-term debt (Note 13) 100 62 Total current liabilities 2,421 3,584 Due to customer (Note 11) 770 - Long-term debt (Note 13) 3,220 3,240 Total liabilities 6,411 6,824 Stockholders' Equity Series A Preferred stock par value $ 0.0001 ; 25,000,000 shares authorized; one share issued and outstanding (Note 15) - - Common stock par value $ 0.0001 ; 250,000,000 shares authorized; 47,528,908 shares issued and outstanding (2023 – 47,469,224 ) (Note 15) 5 5 Additional paid-in capital 171,792 170,370 Additional paid-in capital – Warrants (Note 20) 20,385 20,385 Accumulated deficit ( 176,970 ) ( 155,883 ) Accumulated other comprehensive loss ( 1,070 ) ( 1,141 ) Total stockholders' equity 14,142 33,736 Total liabilities and stockholders' equity $ 20,553 $ 40,560 Going Concern (Note 1) Commitments (Note 24) See accompanying notes to the consolidated financial statements . F-2 Table of Contents Loop Industries, Inc. Consolidated Statements of Operations and Comprehensive Loss (in thousands of U.S. dollars, except for share data) Years Ended February 29, 2024 February 28, 2023 Revenue $ 153 $ 173 Expenses : Research and development (Note 16) 11,379 17,346 General and administrative (Note 17) 9,988 20,429 Depreciation and amortization (Notes 7 and 8) 535 550 Total expenses 21,902 38,325 Other (income) loss : Gain on disposition of land (Note 7) - ( 16,683 ) Interest and other financial expenses (income) (Note 21) ( 41 ) 189 Interest income ( 558 ) ( 41 ) Foreign exchange gain ( 63 ) ( 316 ) Net loss ( 21,087 ) ( 21,301 ) Other comprehensive income (loss) - Foreign currency translation adjustment 71 ( 1,045 ) Comprehensive loss $ ( 21,016 ) $ ( 22,346 ) Net loss per share Basic and diluted $ ( 0.44 ) $ ( 0.45 ) Weighted average common shares outstanding Basic and diluted 47,522,483 47,418,949 Going Concern (Note 1) See accompanying notes to the consolidated financial statements. F-3 Table of Contents Loop Industries, Inc. Consolidated Statements of Changes in Stockholders’ Equity For the Years Ended February 29, 2024 and February 28, 2023 (in United States dollars) (in thousands of U.S. dollars, except for share data) Year ended February 29, 2024 Common stock Preferred stock Additional Accumulated par value $0.0001 par value $0.0001 Additional Paid-in Other Total Number of Shares Amount Number of Shares Amount Paid-in Capital Capital - Warrants Accumulated Deficit Comprehensive Loss Stockholders' Equity Balance, February 28, 2023 47,469,224 $ 5 1 $ - $ 170,370 $ 20,385 $ ( 155,883 ) $ ( 1,141 ) $ 33,736 Issuance of shares upon the vesting of restricted stock units (Notes 15 and 18) 51,963 - - - - - - - - Issuance of shares upon the exercise of stock options (Notes 15 and 18) 7,721 - - - - - - - - Stock options issued (Note 18) - - - - 644 - - - 644 Restricted stock units issued (Note 18) - - - - 778 - - - 778 Foreign currency translation - - - - - - - 71 71 Net loss - - - - - - ( 21,087 ) - ( 21,087 ) Balance, February 29, 2024 47,528,908 $ 5 1 $ - $ 171,792 $ 20,385 $ ( 176,970 ) $ ( 1,070 ) $ 14,142 Going Concern (Note 1) See accompanying notes to the consolidated financial statements. F-4 Table of Contents Loop Industries, Inc. Consolidated Statements of Changes in Stockholders’ Equity For the Years Ended February 29, 2024 and February 28, 2023 (continued) (in United States dollars) (in thousands of U.S. dollars, except for share data) Year ended February 28, 2023 Common stock Preferred stock Additional Accumulated par value $0.0001 par value $0.0001 Paid-in Other Total Number of Shares Amount Number of Shares Amount Additional Paid-in Capital Capital - Warrants Accumulated Deficit Comprehensive Loss Stockholders' Equity Balance, February 28, 2022 47,388,056 $ 5 1 $ - $ 150,397 $ 30,272 $ ( 134,582 ) $ ( 96 ) $ 45,996 Issuance of shares upon the vesting of restricted stock units (Notes 15 and 18) 81,168 - - - - - - - - Expiration of warrants (Note 20) - - - - 9,887 ( 9,887 ) - - - Stock options issued (Note 18) - - - - 1,316 - - - 1,316 Restricted stock units issued (Note 18) - - - - 8,770 - - - 8,770 Foreign currency translation - - - - - - - ( 1,045 ) ( 1,045 ) Net loss - - - - - - ( 21,301 ) - ( 21,301 ) Balance, February 28, 2023 47,469,224 $ 5 1 $ - $ 170,370 $ 20,385 $ ( 155,883 ) $ ( 1,141 ) $ 33,736 Going Concern (Note 1) See accompanying notes to the consolidated financial statements. F-5 Table of Contents Loop Industries, Inc. Consolidated Statements of Cash Flows (in United States dollars) (in thousands of U.S. dollars) February 29, 2024 February 28, 2023 Cash Flows from Operating Activities Net loss $ ( 21,087 ) $ ( 21,301 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization (Notes 7 and 8) 535 550 Stock-based compensation (Note 18) 1,422 10,086 Write-down of inventory (Note 4) 817 - Discount on due to customer (Note 11) ( 238 ) - Gain on disposition of land (Note 7) - ( 16,683 ) Payment of legal settlement, net (Note 23) - ( 2,262 ) Accretion and accrued interest (Notes 11, 13 and 21) 79 156 Changes in operating assets and liabilities: Sales tax and tax credits receivable (Note 3) 731 548 Inventories (Note 4) ( 187 ) ( 727 ) Prepaid expenses and other deposits (Note 6) 87 ( 696 ) Accounts payable and accrued liabilities (Note 10) ( 193 ) ( 4,563 ) Net cash used in operating activities ( 18,034 ) ( 34,892 ) Cash Flows from Investing Activities Proceeds from disposition of land (Note 7) - 22,314 Deposits on machinery and equipment (Note 5) - ( 594 ) Additions to property, plant and equipment (Note 7) ( 5,162 ) ( 81 ) Additions to intangible assets (Note 8) ( 482 ) ( 360 ) Net cash (used in) provided by investing activities ( 5,644 ) 21,279 Cash Flows from Financing Activities Customer deposits (Note 11) ( 12 ) 1,012 Repayment of long-term debt (Note 13) ( 63 ) - Net cash (used in) provided by financing activities ( 75 ) 1,012 Effect of exchange rate changes 120 ( 870 ) Net change in cash, cash equivalents and restricted cash ( 23,633 ) ( 13,471 ) Cash, cash equivalents and restricted cash, beginning of year 30,591 44,062 Cash, cash equivalents and restricted cash, end of year $ 6,958 $ 30,591 Supplemental Disclosure of Cash Flow Information: Income tax paid $ - $ - Interest paid $ 118 $ - Interest received $ 488 $ 41 Going Concern (Note 1) See accompanying notes to the consolidated financial statements. F-6 Table of Contents Loop Industries, Inc. February 29, 2024 and February 28, 2023 Notes to the Consolidated Financial Statements (in thousands of United States dollars except where otherwise indicated) 1. The Company and Basis of Presentation and Going Concern The Company Loop Industries, Inc. (the “Company,” “Loop,” “we,” or “our”) is a technology company that owns patented and proprietary technology that depolymerizes no and low-value waste polyethylene terephthalate (“PET”) plastic and polyester fiber to its base building blocks (monomers). The monomers are filtered, purified and polymerized to create virgin-quality Loop ™ branded PET resin suitable for use in food-grade packaging and polyester fiber. The Company is currently in the pre-commercialization stage with limited revenues. Basis of presentation These consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“US GAAP”) and comprise the consolidated financial position and results of operations of Loop Industries, Inc. and its subsidiaries, Loop Innovations, LLC and Loop Canada Inc. All subsidiaries are, either directly or indirectly, wholly owned subsidiaries of Loop Industries, Inc. (collectively, the “Company”). The Company also owns, through Loop Innovations, LLC, a 50 % interest in a joint venture, Indorama Loop Technologies, LLC, which is accounted for under the equity method. Intercompany balances and transactions are eliminated on consolidation. The consolidated financial statements of the Company have been prepared on a going concern basis, which contemplates the continuing of operations, the realization of assets and the settlement of liabilities in the normal course of business. All monetary amounts in these notes to the condensed consolidated financial statements are in thousands of U.S. dollars unless otherwise specified, except for per share data. Going Concern These consolidated financial statements have been prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and settlement of liabilities in the normal course of business as they come due. In assessing whether the going concern assumption is appropriate, management takes into account all available information about the future, which is at least, but not limited to, twelve months from the date of issuance of these consolidated financial statements. Since its inception, the Company has been in the pre-commercialization stage with no material revenues from customers, and its ongoing operations and commercialization plans have been financed primarily by raising equity. Therefore, the Company has incurred net losses and negative cash flow from operating and investing activities since its inception and expects to incur additional net losses while it continues to develop and plan for commercialization. As at February 29, 2024, the Company’s available liquidity was $ 9,537 , consisting of cash and cash equivalents of $ 6,958 and an undrawn senior loan facility from a Canadian bank of $ 2,579 . Management continuously monitors the Company’s cash resources against its short-term cash commitments to ensure there is sufficient liquidity to fund its costs for at least twelve months from the financial statement issuance date. Management evaluates the Company’s liquidity to determine if there is substantial doubt about its ability to continue as a going concern. In preparing this going concern assessment, management applies significant judgment in estimating future cash flow requirements of the Company based on budgets and forecasts, which includes developing assumptions related to the estimation of amount and timing of future cash outflows and inflows. Based on its assessment, management estimates that current available liquidity and forecasted net cash flows will not be sufficient to meet the Company’s obligations, commitments and budgeted expenditures the next twelve months from the consolidated financial statements issuance date. These events and conditions are material uncertainties that raise substantial doubt upon the Company’s ability to continue as a going concern and accordingly, the appropriateness of the use of accounting principles applicable to a going concern. F-7 Table of Contents The Company’s ability to move to the next stage of its strategic development and construct manufacturing plants is dependent on, among other factors, whether the Company can obtain the necessary financing through a combination of the issuance of debt, equity, and/or joint ventures, and/or government incentive programs and/or customers. However, there is no assurance that the Company will be successful in attracting additional funding. Even if additional financing is available, it may not be available on terms favorable to the Company. Failure to secure additional financing on favorable terms when it becomes required would have an adverse effect on the Company’s financial position and on its ability to execute its business plan. The Company is seeking to finalize the negotiation of previously announced financing initiatives on acceptable terms, although there is no assurance it will succeed. These consolidated financial statements do not reflect the adjustments to the carrying values of assets and liabilities and the reported expenses and balance sheet classifications that would be necessary if the Company were unable to realize its assets and settle its liabilities as a going concern in the normal course of operations. Such adjustments could be material. 2. Summary of Significant Accounting Policies Revenue recognition The Company recognizes revenue with customers in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). This standard applies to all contracts with customers, except for contracts with customers that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under ASC 606, the Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. The Company enters into contracts with customers to sell Loop ™ PET resin. These contracts include a single performance obligation, which is the delivery of Loop ™ PET resin, and the transaction price is a fixed rate per delivered volume. Revenue is recognized when control of the product transfers to the customer, which is when product is delivered to the customer location. Shipping and handling costs are accounted for as a fulfillment cost. Use of estimates The preparation of financial statements in conformity with US GAAP requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include the going concern assessment, the net realizable value of inventories, estimates for depreciable lives of property, plant and equipment and intangible assets, recoverability of tax credits receivable, assumptions made in calculating the fair value of stock-based compensation and other equity instruments, and the assessment of performance conditions for stock-based compensation awards. Fair value of financial instruments The Company applies Financial Accounting Standards Board (“FASB”) Codification (“ASC”) 820, Fair Value Measurement , which defines fair value and establishes a framework for measuring fair value and making disclosures about fair value measurements. FASB ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability used in measuring financial instruments at fair value. Market price observability is impacted by a number of factors, including the type of financial instruments and the characteristics specific to them. Financial instruments with readily available quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value. F-8 Table of Contents There are three levels within the hierarchy that may be used to measure fair value: Level 1 – A quoted price in an active market for identical assets or liabilities. Level 2 – Significant pricing inputs that are observable, which are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Level 3 – Significant pricing inputs that are unobservable, which are inputs that reflect the Company’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value measurements level of an asset or liability within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used should maximize the use of observable inputs and minimize the use of unobservable inputs. The valuation methodologies described above may produce a fair value calculation that may not be indicative of future net realizable value or reflective of future fair values. The fair value of cash, cash equivalents and accounts payable and accrued liabilities approximate their carrying values due to their short-term maturity. Research and development expenses Research and development costs are charged to expense as costs are incurred in performing research and development activities. Research and development expenses relate primarily to process development and design, customer trials and characterization studies, testing of pre-production samples, machinery and equipment expenditures for use in the production facility in Terrebonne, Québec (the “Terrebonne Facility”), compensation, and consulting and engineering fees. Research and development costs are presented net of related tax credits and government grants. Government grants US GAAP for profit-oriented entities does not define government grants; nor is there specific guidance applicable to government grants. Under the Company’s accounting policy for government grants and consistent with non-authoritative guidance, grants are recognized on a systematic basis over the periods in which the entity recognizes the related costs. Grants that relate to the acquisition of an asset are recognized as a reduction of the cost of the asset and in the statement of operations and comprehensive loss as the asset is depreciated or amortized. A grant that is compensation for expenses or losses already incurred, or for which there are no future related costs, is recognized in the statement of operations and comprehensive loss in the period in which it becomes receivable. Low-interest loans or interest-free loans from a government are initially measured at fair value and an interest expense is recognized on the loan subsequently under the effective interest method, with the difference recognized as a government grant. Reimbursable tax credits are recognized when amounts can be reasonably estimated on a systematic basis over the periods in which the Company recognizes the related costs. The Company is currently eligible for reimbursable Provincial research and development tax credits and investment tax credits, which are related to costs associated with our Terrebonne Facility and recorded as a reduction of research and development expenses. Deferred financing costs, debt discounts, discount on due to customer and other transaction costs Deferred financing costs represent commitment fees, legal fees and other costs associated with obtaining commitments for financing. These fees are amortized as a component of interest expense over the terms of the respective financing agreements using the effective interest rate method. Unamortized deferred financing fees are expensed in full when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financial transactions that do not close are expensed in the period in which it is determined that the financing will not be successful. Transaction costs associated with issuing equity are reflected as a reduction of accumulated paid-in-capital. F-9 Table of Contents Foreign currency translations and transactions The accompanying consolidated financial statements are presented in U.S. dollars, the reporting currency of the Company. Assets and liabilities of subsidiaries that have a functional currency other than that of the Company are translated to U.S. dollars at the exchange rate as at the balance sheet date. Income and expenses are translated at the average exchange rate of the period. The resulting translation adjustments are included in other comprehensive income (loss) (“OCI”). The Company currently is not engaged in any currency hedging activities. For transactions and balances, monetary assets and liabilities denominated in foreign currencies are translated into the functional currency of the entity at the prevailing exchange rate at the reporting date. Non-monetary assets and liabilities, and revenue and expense items denominated in foreign currencies are translated into the functional currency using the exchange rate prevailing at the dates of the respective transactions. Foreign exchange gains and losses resulting from the settlement of such transactions are recognized in the consolidated statements of operations and comprehensive loss, except for gains or losses arising from the translation of intercompany balances denominated in foreign currencies that forms part in the net investment in the subsidiary which are included in OCI. Property, plant and equipment Property, plant and equipment are recorded at cost, net of accumulated amortization and impairment, and are amortized over their estimated useful lives at the time they are put to use, unless the useful life is indefinite, using the straight-line method over the following periods: Building 30 years Land Indefinite Office equipment and furniture 8 years Building and land improvements 5 - 10 years Costs related to repairs and maintenance of property, plant and equipment are expensed in the period in which they are incurred. Upon sale or disposal, the Company writes off the cost of the asset and the related amount of accumulated depreciation. The resulting gain or loss is included in the consolidated statement of operations and comprehensive loss. Management reviews the carrying values of its property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. Assets are grouped at the lowest level for which identifiable cash flows are largely independent when testing for, and measuring for, impairment. In performing its review of recoverability, the Company estimates the future cash flows expected to result from the use of the asset or asset group and its eventual disposition. If the sum of the expected undiscounted future cash flows is less than the carrying amount of the asset or asset group, an impairment loss is recognized in the consolidated statements of operations. Measurement of the impairment loss is based on the excess of the carrying amount of the asset or asset group over the fair value calculated using discounted expected future cash flows. Stock‑based compensation The Company periodically issues stock options, warrants and restricted stock units to employees and non-employees in non-capital raising transactions for services and financing expenses. The Company accounts for stock options granted to employees based on the authoritative guidance provided by the FASB wherein the fair value of the award is measured on the grant date and recognized as compensation expense on the straight-line basis over the vesting period. When performance conditions exist, the Company recognizes compensation expenses when it becomes probable that the performance condition will be met. Forfeitures on share-based payments are recognized as they occur. The Company accounts for stock options and warrants granted to non-employees in accordance with the authoritative guidance of the FASB wherein the fair value of the stock compensation is based upon the measurement date determined as the earlier of the date at which either a) a commitment is reached with the counterparty for performance or b) the counterparty completes its performance. F-10 Table of Contents The Company estimates the fair value of restricted stock unit awards to employees and directors based on its intrinsic value at date of grant. The fair value of the stock options granted is estimated using the Black-Scholes model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options, and future dividends. Stock-based compensation expense is recorded based on the value derived from the Black-Scholes model and on actual experience. The assumptions used in the Black-Scholes model could materially affect stock-based compensation expenses recorded in the current and future periods. Inventories Inventories are stated at the lower of cost or net realizable value using the average cost method. Inventory cost includes direct labor, cost of raw materials and production overhead costs. Inventories expensed during the year are classified as research and development expenses in the consolidated statement of operations and comprehensive loss. The Company separates its inventories into three main categories: raw materials, work in process, and finished goods. The raw materials category includes goods used in the production process that have not yet entered the production process at the balance sheet date and mainly comprises chemicals and other process consumables. The work in process category includes goods that are in the production process at the balance sheet date and mainly comprises recycled monomers that have not yet been polymerized into Loop ™ branded PET resin. The finished goods category includes goods that have completed the production process at the balance sheet date and mainly comprises Loop ™ branded PET resin. Restricted cash Cash held by the Company restricted as to withdrawal or use is presented as restricted cash in the consolidated balance sheet. As at February 28, 2023, restricted cash comprised a customer deposit which is restricted for use on a commercial project, as discussed in Note 11. There was no restricted cash as at February 29, 2024. Intangible assets Intangible assets are recorded at cost, net of accumulated amortization and impairment, and are amortized using the straight-line method over 7 years, unless the useful life is deemed to be indefinite. The Company reviews the carrying value of intangible assets subject to amortization whenever events or changes in circumstances indicate that the carrying amount of an intangible asset or asset group might not be recoverable or a change in the remaining useful life of an intangible asset. If the carrying value of an asset exceeds its undiscounted cash flows, the Company writes down the carrying value of the intangible asset to its fair value in the period identified. If the carrying value of assets is determined not to be recoverable, the Company records an impairment loss equal to the excess of the carrying value over the fair value of the assets. The Company’s estimate of fair value is based on the best information available, in the absence of quoted market prices. The Company generally calculates fair value as the present value of estimated future cash flows that the Company expects to generate from the asset. If the estimate of an intangible asset’s remaining useful life is changed, the Company amortizes the remaining carrying value of the intangible asset prospectively over the revised remaining useful life. Income taxes The Company calculates its provision for income tax on the basis of the tax laws enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income, in accordance with FASB ASC 740, Income Taxes . The Company uses an asset and liability approach for financial accounting and reporting for income taxes that allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax expense. F-11 Table of Contents Net earnings (loss) per share The Company computes net loss per share in accordance with FASB ASC 260, Earnings Per Share . Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year. The Company includes common stock issuable in its calculation. Diluted earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Potential common shares are excluded from the computation if their effect is antidilutive. For the years ended February 29, 2024 and February 28, 2023, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have an antidilutive effect. As at February 29, 2024, the potentially dilutive securities consisted of 2,772,000 outstanding stock options (2023 – 2,542,000 ), 4,368,897 outstanding restricted stock units (2023 – 3,888,618 ), and 7,089,400 outstanding warrants (2023 – 7,089,400 ). Recently issued accounting pronouncements not yet adopted In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2023-09—Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures. The amendments in this Update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information and includes certain other amendments to improve the effectiveness of income tax disclosures. The updated standard is effective for our annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial statements, other than additional disclosures in our notes to the consolidated financial statements. In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. The updated standard is effective for our annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. Early adoption is permitted. We are currently evaluating the impact that the updated standard will have on our financial statement disclosures. The Company has determined that all other recently issued accounting pronouncements will not have a material impact on the Company’s consolidated financial statements or do not apply to its operations. 3. Sales Tax, Tax Credits and Other Receivables Sales tax, research and development tax credits and other receivables as at February 29, 2024 and February 28, 2023 were as follows: February 29, 2024 February 28, 2023 Sales tax $ 75 $ 170 Investment tax credits - 461 Research and development tax credits 160 402 Interest income receivable 70 - Other receivables 46 42 $ 351 $ 1,075 The Company is registered for the Canadian federal and provincial goods and services taxes. As such, the Company is obligated to collect from third parties, and is entitled to claim sales taxes paid on its expenses and capital expenditures incurred in Canada. In addition, Loop Canada Inc. is entitled to receive government assistance in the form of refundable and non-refundable research and development tax credits from the federal and provincial taxation authorities, based on qualifying expenditures incurred during the fiscal year. The refundable credits are from the provincial taxation authorities and are not dependent on its ongoing tax status or tax position and accordingly are not considered part of income taxes. The Company records refundable tax credits as a reduction of research and development expenses when the Company can reasonably estimate the amounts and it is more likely than not, they will be received. During the year ended February 29, 2024, the Company recorded tax credits of $ 263 (2023 – $ 362 ) as a reduction of research and development expenses and received $ 510 (2023 – $ 250 ) from taxation authorities for research and development tax credits, net of fees. F-12 Table of Contents The Company is also eligible for non-refundable research and development tax credits from the federal taxation authorities which can be used as a reduction of income tax expense in any given year to the extent the Company has taxable income. The Company has not had taxable income since inception and has not been able to use these non-refundable federal research and development tax credits. During the year ended February 29, 2024, the Company was eligible for non-cash research and development tax credits in the amount of $ 432 (2023 – $ 765 ). These non-cash tax credits, which have an unlimited carry forward period are not recognized in the Company’s consolidated financial statements. As at February 29, 2024, the carry forward balance of non-cash research and development tax credits was $ 2,519,195 (2023 - $ 1,979,978 ). Loop Canada Inc. is also eligible for refundable investment tax credits from the provincial taxation authorities based on qualifying expenditures for manufacturing equipment. The Company records refundable tax credits as a reduction of research and development expenses when the Company can reasonably estimate the amounts and it is more likely than not, they will be received. During the year ended February 29, 2024, the Company recorded investment tax credits of $ 56 (2023 – $ 837 ) as a reduction of research and development expenses and received $ 522 (2023 – $ 348 ) from taxation authorities for investment tax credits. 4. Inventories Inventories as at February 29, 2024 and February 28, 2023 were as follows: February 29, 2024 February 28, 2023 Finished goods $ 552 $ 242 Work in process 333 467 Raw materials 34 18 Allowance for inventory write-down ( 817 ) - $ 102 $ 727 As at February 29, 2024 and February 28, 2023, inventories included finished goods, work in process and raw materials. Finished goods inventories consist of bottle grade and fiber grade Loop ™ PET resin which is intended to be sold to customers. Work in process inventories consist of recycled monomers (dimethyl terephthalate (“rDMT”) and monoethylene glycol (“rMEG”)), either purified or yet to be purified, resulting from the depolymerization of PET feedstock. These monomers are intended be polymerized into Loop ™ PET resin in the future. Raw materials inventories consist of chemicals which are used as inputs in the PET depolymerization process. As at February 29, 2024 and February 28, 2023, finished goods and work in process inventories were presented at their net realizable value, while raw materials were presented at average cost. As at February 29, 2024, the Company recorded an allowance for inventory write-down of $ 817 (2023 – nil) on finished goods and work in process inventories related to inventory volumes not expected to be sold in the next twelve months. 5. Deposits on Machinery and Equipment As at February 28, 2023, the Company had $ 3,395 of non-refundable cash deposits on long-lead equipment that are intended to be used in a planned Infinite Loop ™ manufacturing facility. During the year ended February 29, 2024, the Company made additional payments of $ 5,065 on the long-lead equipment and on December 20, 2023 ownership was transferred to the Company. The total carrying amount of $ 8,460 related to the long-lead equipment is presented in property, plant and equipment as at February 29, 2024 (Note 7), with no amounts remaining as deposits. 6. Prepaid Expenses and Other Deposits Prepaid expenses and other deposits as at February 29, 2024 and February 28, 2023 were as follows: February 29, 2024 February 28, 2023 Insurance $ 449 $ 545 Other 128 91 $ 577 $ 636 F-13 Table of Contents 7. Property, Plant and Equipment, net As at February 29, 2024 Cost Accumulated depreciation, write-down and impairment Net book value Machinery and equipment $ 8,460 $ - $ 8,460 Building 1,827 ( 371 ) 1,456 Land 226 - 226 Building and Land Improvements 1,853 ( 1,472 ) 381 Office equipment and furniture 275 ( 162 ) 113 $ 12,641 $ ( 2,005 ) $ 10,636 As at February 28, 2023 Cost Accumulated depreciation, write-down and impairment Net book value Building $ 1,822 $ ( 309 ) $ 1,513 Land 225 - 225 Building and Land Improvements 1,839 ( 1,166 ) 673 Office equipment and furniture 274 ( 140 ) 134 $ 4,160 $ ( 1,615 ) $ 2,545 In December 2021, the Company entered into an agreement for the purchase of long-lead equipment in connection with the construction of a planned Infinite Loop ™ manufacturing facility. Pursuant to the agreement, the Company has paid $ 8,460 , and no additional amounts were owing as at February 29, 2024. During the year ended February 29, 2024, the manufacturing of the long-lead equipment was completed and its ownership was transferred to the Company and is not currently in use. The equipment is being held in storage with the intention to be used in the planned Infinite Loop ™ manufacturing facility in Ulsan, South Korea. Pursuant to the joint venture agreement (the “Agreement”) entered into by the Company and SK Geo Centric Co. Ltd. (“SKGC”) on April 27, 2023, a new entity, owned 51 % by SKGC and 49 % by the Company, will be formed to build and operate the Infinite Loop ™ manufacturing facility in Ulsan. As at February 29, 2024, the long-lead equipment was presented in machinery and equipment at cost, which represents the amount at which it is expected to be transferred to the new entity. Depreciation expense amounted to $ 387 for the year ended February 29, 2024 (2023 – $ 459 ). During the year ended February 28, 2022, the Company acquired land in Bécancour, Québec for cash of $ 4,335 (CDN $5,900) and subsequently incurred civil construction costs of $ 1,074 in land improvements. During the year ended February 28, 2023, the Company sold the land for cash net proceeds of $ 22,314 (CDN $29,900) and a gain on disposition of the asset of $ 16,683 . The table below summarizes the amounts related to the gain on disposition of land: Gross proceeds of disposition $ 22,762 Transaction costs ( 448 ) Net proceeds of disposition 22,314 Cost of land ( 4,335 ) Cost of land improvements ( 1,074 ) Foreign exchange effect ( 222 ) Gain on disposition of land $ 16,683 F-14 Table of Contents 8. Intangible Assets, net As at February 29, As at February 28, 2024 2023 Patents, at cost – beginning of year $ 1,514 $ 1,154 Additions in the year – patents 482 360 Patents, at cost – end of year 1,996 1,514 Patents, accumulated depreciation – beginning of year ( 231 ) ( 140 ) Amortization of patents ( 148 ) ( 91 ) Patents, accumulated depreciation – end of year ( 379 ) ( 231 ) Foreign exchange effect ( 69 ) ( 73 ) Patents, net – end of year $ 1,548 $ 1,210 On April 9, 2019, the first GEN II U.S. patent was issued. During the year ending February 29, 2024, the Company continued to develop its next Generation II (“GEN II”) technology and filed various patents in jurisdictions around the world. The GEN II technology portfolio currently consists of four patent families for which the company has eight issued U.S. patents and five pending U.S. applications. Internationally, the Company also has issued or allowed patents in many foreign jurisdictions, including Algeria, Brazil, Bangladesh, China, India, Indonesia, Japan, Morocco, South Korea, and Taiwan for certain aspects of the technology and pending applications in Canada, China, the Eurasian Patent Organization, Europe, the Gulf Cooperation Council, India, Japan, Mexico, Singapore, South Korea, and various other countries. All patents and patent applications, if granted are expected to expire between 2037 and 2040, not including any patent term extension. Amortization expense amounted to $ 148 for the year ended February 29, 2024 (2023 - $ 91 ). 9. Financial Instruments and Management of Financial Risk Carrying values and fair values The following table presents the fair value of the Company’s financial liabilities at February 29, 2024 and February 28, 2023: Fair Value at February 29, 2024 Carrying Amount Fair Value Level in the hierarchy Financial liabilities measured at amortized cost: Long-term debt $ 3,320 $ 3,377 Level 2 Due to customer $ 770 $ 770 Level 2 Fair Value as at February 28, 2023 Carrying Amount Fair Value Level in the hierarchy Financial liabilities measured at amortized cost: Long-term debt $ 3,302 $ 3,280 Level 2 The fair value of cash, restricted cash, due to customer, other receivables, and accounts payable and accrued liabilities approximate their carrying values due to their short-term maturity. F-15 Table of Contents Currency Risk We are subject to risks associated with currency fluctuations, and changes in foreign currency exchange rates could impact our results of operations. We operate mainly through two entities, Loop Industries, Inc., which is a Nevada corporation and has a U.S. dollar functional currency, and our wholly-owned subsidiary, Loop Canada Inc. (“Loop Canada”), which is based in Terrebonne, Québec, Canada and has a Canadian dollar functional currency. Our reporting currency is the U.S. dollar. We mainly finance our operations through the sale and issuance of shares of common stock of Loop Industries, Inc. in U.S. dollars while our operations are concentrated in our wholly-owned subsidiary, Loop Canada. Accordingly, we are exposed to foreign exchange risk as we maintain bank accounts in U.S. dollars and a significant portion of our operational costs (including payroll, site costs, costs of locally sourced supplies and income taxes) are denominated in Canadian dollars. Significant fluctuations in U.S. dollar to Canadian dollar exchange rates could materially affect our result of operations, cash position and funding requirements. To the extent that fluctuations in currency exchange rates cause our results of operations to differ materially from our expectations or the expectations of our investors, the trading price of our common stock could be adversely affected. 10. Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities as at February 29, 2024 and February 28, 2023 were as follows: February 29, 2024 February 28, 2023 Trade accounts payable $ 602 $ 1,020 Accrued employee compensation 801 712 Accrued engineering fees 511 96 Accrued professional fees 274 410 Other accrued liabilities 133 272 $ 2,321 $ 2,510 11. Customer Deposit & Due to Customer In October 2022, the Company received a cash deposit from a customer of $ 1,000 in relation to an executed capacity reservation agreement. The deposit was intended to be credited against any future sales of Loop ™ PET resin over a five-year period, commencing two years after the first delivery of Loop ™ PET resin to the customer. Under the terms of the capacity reservation agreement, the cash deposit was designated for expenditures related to a planned Infinite Loop ™ manufacturing facility and was refundable to the customer in the event that the Infinite Loop ™ manufacturing facility was not constructed. As the cash deposit was restricted in its use, it was reflected as restricted cash as at February 28, 2023 and a corresponding contract liability was recognized in the consolidated balance sheet. Upon mutual agreement, the capacity reservation agreement with the customer was terminated on January 18, 2024. The customer and the Company agreed for the deposit to be refunded in full on July 1, 2027, with no restriction on the Company’s use of the funds. The amount bears no interest. The cause of the termination is related to the customer’s decision to abandon its plans to incorporate rPET in its products for technical reasons. The Company reclassified the customer deposit as a due to customer and established its fair value at $ 762 based on a discount rate of 8.20 %, which reflected a discount of $ 238 . The discount rate used was based on the external financing from a Canadian bank. The discount on due to customer is amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. During the year ended February 29, 2024, the Company recorded an accretion expense of $ 8 (2023 – nil). 12. Investment in Joint Venture On September 15, 2018, the Company, through its wholly-owned subsidiary Loop Innovations, LLC, a Delaware limited liability company, entered into a Joint Venture Agreement (the “Joint Venture Agreement”) with Indorama Ventures Holdings LP, USA, an indirect subsidiary of Indorama Ventures Public Company Limited, to manufacture and commercialize sustainable polyester resin. Each company has a 50/50 equity interest in Indorama Loop Technologies, LLC (“ILT”), which was specifically formed to operate and execute the joint venture. F-16 Table of Contents ILT meets the accounting definition of a joint venture where neither party has control of the joint venture entity and both parties have joint control over the decision-making process in ILT. As such, the Company uses the equity method of accounting to account for its share of the investment in ILT. There were no operations in ILT from the date of inception of September 24, 2018 to February 29, 2024. During the year ended February 29, 2024, we made no contributions to ILT (2023 – nil). All contributions to ILT, which have been matched by Indorama Ventures, were used to fund engineering design costs which were capitalized in ILT. As at February 29, 2024, the carrying value of the equity investment was $ 381 (2023 – $ 381 ), which represents 50 % of the cash balance in ILT. 13. Long-Term Debt February 29, 2024 February 28, 2023 Investissement Québec financing facility: Principal amount $ 3,353 $ 3,380 Unamortized discount ( 191 ) ( 261 ) Accrued interest 158 183 Total Investissement Québec financing facility 3,320 3,302 Less: current portion of long-term debt ( 100 ) ( 62 ) Long-term debt, net of current portion $ 3,220 $ 3,240 Investissement Québec financing facility On February 21, 2020, the Company received $ 1,628 (CDN$2,209) from Investissement Québec as the first disbursement of our financing facility, out of a maximum of $ 3,390 (CDN$4,600) (the “Financing Facility”). The loan’s interest rate was initially set at 2.36 % and there is a 36-month moratorium on both capital and interest repayments starting on the date of the first disbursement, after which capital and interest is repayable in 84 monthly installments. The Company established the fair value of the loan for the first disbursement at $ 1,354 based on a discount rate of 5.45 %, which reflected a debt discount of $ 291 . The discount rate used was based on the external financing from a Canadian bank. The Company, under the loan agreement, was required to pay fees representing 1% of the loan amount, $ 34 (CDN$46) to Investissement Québec which we deferred and recorded as a reduction of the Financing Facility. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. On August 26, 2021, the Company received $ 1,762 (CDN$2,391) from Investissement Québec as the second disbursement of the Financing Facility, the balance of the total amount available under the Financing Facility. The second disbursement bears the same interest rate and repayment terms as the first disbursement. The Company established the fair value of the loan for the first disbursement at $ 1,750 based on a discount rate of 3.95 %, which reflected a debt discount of $ 139 . The discount rate used was based on the external financing from a Canadian bank. There were no fees associated with the second disbursement. Debt discount and deferred financing expenses are amortized to “Interest and other financial expenses” in our Consolidated Statements of Operations and Comprehensive Loss. The Company recorded interest expense on the Investissement Québec loan for the year ended February 29, 2024 in the amount of $ 84 (2023 – $ 86 ) and an accretion expense of $ 71 (2023 – $ 70 ). The Company also agreed to issue to Investissement Québec warrants to purchase shares of common stock of the Company in an amount equal to 10% of each disbursement up to a maximum aggregate amount of $ 339 (CDN$460). The exercise price of the warrants is equal to the higher of (i) $ 11 .00 per share and (ii) the ten-day weighted average closing price of Loop shares of common stock on the Nasdaq stock market for the 10 days prior to the issue of the warrants. The warrants can be exercised immediately upon grant and have a term of three years from the date of issuance. The loan can be repaid at any time by the Company without penalty. In connection with the first disbursement of the Financing Facility, the Company issued a warrant (“First Disbursement Warrant”) to acquire 15,153 shares of common stock at a strike price of $ 11 .00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $ 78 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. In connection with the second disbursement of the Financing Facility, the Company issued a warrant (“Second Disbursement Warrant”) to acquire 17,180 shares of common stock at a strike price of $ 11 .00 per share to Investissement Québec. The Company determined the fair value of the warrants using the Black-Scholes pricing formula. The fair value of the First Disbursement Warrant was determined to be $ 69 and is included in “Additional paid-in capital – Warrants” in our Condensed Consolidated Balance Sheets. The First Disbursement Warrants expired in the year ended February 28, 2023 and the Second Disbursement Warrants remain outstanding as at February 29, 2024. F-17 Table of Contents On November 21, 2022, the Company and Investissement Québec entered into an agreement to amend the existing Financing Facility which modifies the repayments of the principal amount (the “Financing Facility Amendment”). As per the Financing Facility Amendment, a total of $ 37 (CDN $50) of the principal amount was repayable in monthly installments in the fiscal year ended February 29, 2024, with the remainder of the principal amount being repayable in 72 monthly installments. On February 28, 2024, the Company and Investissement Québec entered into an agreement to amend the existing Financing Facility which modifies the repayments of the principal amount (the “Second Financing Facility Amendment”). As per the Second Financing Facility Amendment, a total of $ 74 (CDN $100) of the principal amount is repayable in monthly installments in the fiscal year ending February 28, 2025, with the remainder of the principal amount being repayable in 60 monthly installments. Pursuant to the Second Financing Facility Amendment the interest rate of the Financing Facility was increased from 2.36 % to 3.36 %. Under the original terms of the Financing Facility, the principal amount was repayable in 84 monthly installments beginning in March of 2023. The amendments do not modify the repayment terms of accrued interest or any of the other terms of the Financing Facility that are not mentioned above. The amendments did not meet the criteria of ASC 470, Debt for an extinguishment of debt as the amendments did not substantially modify the terms of the Financing Facility. The Company therefore applied modification accounting and no immediate gain or loss was recognized related to the amendments. Total repayments due on the Company’s indebtedness over the next five years are as follows: Years ending Amount February 28, 2025 $ 100 February 28, 2026 682 February 28, 2027 682 February 29, 2028 682 February 28, 2029 682 Thereafter 683 Total $ 3,511 Credit facility from a Canadian bank On July 26, 2022, Loop Canada, Inc., a wholly-owned subsidiary of the Company, entered into an Operating Credit Facility (the “Credit Facility”) with a Canadian bank. The Credit Facility allows for borrowings of up to $ 2,579 (CDN $3,500) in aggregate principal amount and provides for a two-year term on amounts drawn. The Credit Facility is secured by the Company’s Terrebonne, Québec property and is subject to a minimum equity covenant, tested quarterly with which the Company was in compliance as at February 29, 2024. All borrowings under the Credit Facility will bear interest at an annual rate equal to the bank’s Canadian prime rate plus 1 .0%. As at February 29, 2024, the $ 2,579 (CDN $3,500) Credit Facility was available and undrawn. 14. Related Party Transactions Employment Agreement On June 29, 2015, the Company entered into an employment agreement with Mr. Daniel Solomita, the Company’s President and Chief Executive Officer (“CEO”). The employment agreement is for an indefinite term. F-18 Table of Contents On July 13, 2018, the Company and Mr. Solomita entered into an amendment and restatement of the employment agreement which provided for a long-term incentive grant of 4,000,000 shares of the Company’s common stock, in tranches of one million shares each, upon the achievement of four performance milestones. This was modified to provide a grant of 4,000,000 restricted stock units covering 4,000,000 shares of the Company’s common stock while the performance milestones remained the same. The grant of the restricted stock units became effective upon approval by the Company’s stockholders at the Company’s 2019 annual meeting, of an increase in the number of shares available for grant under the 2017 Equity Incentive Plan (the “Plan”). Such approval was granted by the Company’s stockholders at the Company’s 2019 annual meeting. The restricted stock units vest upon the achievement of applicable performance milestones, as follows: i) 1,000,000 shares of common stock shall be issued to Mr. Solomita when the Company’s securities are listed on an exchange or the OTCQX tier of the OTC Markets; ii) 1,000,000 shares of common stock shall be issued to Mr. Solomita when the Company executes a contract for a minimum quantity of 25,000 M/T of DMT/MEG or a PET; iii) 1,000,000 shares of common stock shall be issued to Mr. Solomita when the Company’s first full-scale production facility is in commercial operation; and iv) 1,000,000 shares of common stock shall be issued to Mr. Solomita when the Company’s second full-scale production facility is in commercial operation. During the year ended February 28, 2017, it became probable that the first milestone would be met. Accordingly, 1,000,000 performance incentive shares of common stock with a fair value of $ 800,000 were earned and issuable to Mr. Solomita. This amount was reflected as stock-based compensation expense during the year ended February 28, 2017 based on the grant date fair value. The 1,000,000 performance incentive shares of common stock were replaced by vested restricted stock units, of which 200,000 were settled in October 2019, 2020 and 2021, each. On April 30, 2020, the Company and Mr. Solomita entered into an amendment of Mr. Solomita’s employment agreement. The amendment clarified the milestones consistent with the shift in the Company’s business from the production of terephthalate to the production of dimethyl terephthalate, another proven monomer used to produce PET plastic. As at February 29, 2024, 3,400,000 (2023 – 3,400,000 ) of Mr. Solomita’s RSUs were outstanding of which 1,400,000 were vested (2023 – 1,400,000 ). When a milestone becomes probable, the corresponding expense will be valued based on the grant date fair value on April 30, 2020, the date of the last modification of Mr. Solomita’s employment agreement. The closing price of the Company’s common stock on the Nasdaq on April 30, 2020 was $ 7.74 per share. The vested units are settled annually in tranches of 200,000 units on October 15 of each year, unless Mr. Solomita and the Company elect to defer settlement before such date. The unvested 2,000,000 RSUs would be forfeited if Mr. Solomita left the Company, except in the case of termination without cause or resignation for good reason, in which case he would receive 50% of the unvested RSUs at the time of termination, or 100% in the case of termination without cause or resignation for good reason within 24 months after a change in control . During the year ended February 28, 2023, Mr. Solomita met a performance milestone in relation to the signature of a supply agreement with a customer. Accordingly, 1,000,000 performance incentive RSUs with a total fair value of $ 7,740 were earned and issuable to Mr. Solomita. This amount was reflected as stock-based compensation expense during the year ended February 28, 2023. On October 14, 2022, Mr. Solomita and the Company agreed to defer by one year the settlement of 400,000 RSUs that were set to settle on October 15, 2022. On October 12, 2023, Mr. Solomita and the Company agreed to defer by one year the settlement of 800,000 RSUs that were set to settle on October 15, 2023. During the year ended February 29, 2024, no outstanding milestones were probable of being met and, accordingly, no additional stock-based compensation expense was recorded. 15. Stockholders’ Equity Series A Preferred Stock Mr. Solomita’s amended employment agreement of February 15, 2016 provided that the Company shall issue to Mr. Solomita one share of the Company’s Series A Preferred Stock in exchange for Mr. Solomita agreeing not to terminate his employment with the Company for a period of five years from the date of the amendment. The amendment effectively provides Mr. Solomita with a “change of control” provision over the Company in the event that his ownership of the issued and outstanding shares of common stock of the Company is diluted to less than a majority. In order to issue Mr. Solomita his one share of Series A Preferred Stock under the amendment, the Company created a “blank check” preferred stock. Subsequently, the Board of Directors of the Company approved a Certificate of Designation creating the Series A Preferred Stock, and the Company issued one share of Series A Preferred Stock to Mr. Solomita. F-19 Table of Contents The one share of Series A Preferred Stock issued to Mr. Solomita holds a majority of the total voting power so long as Mr. Solomita holds not less than 7.5% of the total number of outstanding shares of our common stock on February 12, 2016 (as adjusted for any stock splits and stock dividends effected after February 12, 2016), assuring Mr. Solomita of control of the Company in the event that his ownership of the issued and outstanding shares of common stock of the Company is diluted to a level below a majority. Currently, Mr. Solomita’s ownership of 19,210,000 shares of common stock and 1 share of Series A Preferred Stock provides him with 75.7% of the voting control of the Company . Additionally, the one share of Series A Preferred Stock issued to Mr. Solomita contains protective provisions, which preclude the Company from taking certain actions without Mr. Solomita’s (or that of any person to whom the one share of Series A Preferred Stock is transferred) approval. More specifically, so long as any shares of Series A Preferred Stock are outstanding, the Company shall not, without first obtaining the approval (by vote or written consent, as provided by law) of the holders of at least a majority of the then outstanding shares of Series A Preferred Stock, voting as a separate class: (a) amend the Articles of Incorporation or, unless approved by the Board of Directors, including by the Series A Director, amend the Company’s By-laws; (b) change or modify the rights, preferences or other terms of the Series A Preferred Stock, or increase or decrease the number of authorized shares of Series A Preferred Stock; (c) reclassify or recapitalize any outstanding equity securities, or, unless approved by the Board of Directors, including by the Series A Director, authorize or issue, or undertake an obligation to authorize or issue, any equity securities or any debt securities convertible into or exercisable for any equity securities (other than the issuance of stock-options or securities under any employee option or benefit plan); (d) authorize or effect any transaction constituting a Deemed Liquidation (as defined in this subparagraph) under the Articles, or any other merger or consolidation of the Company; (e) increase or decrease the size of the Board of Directors as provided in the By-laws of the Company or remove the Series A Director (unless approved by the Board of Directors, including the Series A Director); (f) declare or pay any dividends or make any other distribution with respect to any class or series of capital stock (unless approved by the Board of Directors, including the Series A Director); (g) redeem, repurchase or otherwise acquire (or pay into or set aside for a sinking fund for such purpose) any outstanding shares of capital stock (other than the repurchase of shares of common stock from employees, consultants or other service providers pursuant to agreements approved by the Board of Directors under which the Company has the option to repurchase such shares at no greater than original cost upon the occurrence of certain events, such as the termination of employment) (unless approved by the Board of Directors, including the Series A Director); (h) create or amend any stock option plan of the Company, if any (other than amendments that do not require approval of the stockholders under the terms of the plan or applicable law) or approve any new equity incentive plan; (i) replace the President and/or Chief Executive Officer of the Company (unless approved by the Board of Directors, including the Series A Director); (j) transfer assets to any subsidiary or other affiliated entity (unless approved by the Board of Directors, including the Series A Director); (k) issue, or cause any subsidiary of the Company to issue, any indebtedness or debt security, other than trade accounts payable and/or letters of credit, performance bonds or other similar credit support incurred in the ordinary course of business, or amend, renew, increase or otherwise alter in any material respect the terms of any indebtedness previously approved or required to be approved by the holders of the Series A Preferred Stock (unless approved by the Board of Directors, including the Series A Director); F-20 Table of Contents (l) modify or change the nature of the Company’s business; (m) acquire, or cause a Subsidiary of the Company to acquire, in any transaction or series of related transactions, the stock or any material assets of another person, or enter into any joint venture with any other person (unless approved by the Board of Directors, including the Series A Director); or (n) sell, transfer, license, lease or otherwise dispose of, in any transaction or series of related transactions, any material assets of the Company or any Subsidiary outside the ordinary course of business (unless approved by the Board of Directors, including the Series A Director). Common Stock For the year ended February 29, 2024 Number of shares Amount Balance, February 28, 2023 47,469,224 $ 5 Issuance of shares upon settlement of restricted stock units 51,963 - Issuance of shares upon the exercise of stock options 7,721 - Balance, February 29, 2024 47,528,908 $ 5 For the year ended February 28, 2023 Number of shares Amount Balance, February 28, 2022 47,388,056 $ 5 Issuance of shares upon settlement of restricted stock units 81,168 - Balance, February 28, 2023 47,469,224 $ 5 During the year ended February 29, 2024, the Company recorded the following common stock transactions: (i) The Company issued 51,963 shares of the common stock to settle restricted stock units that vested in the period. (ii) The Company issued 7,721 shares of the common stock to settle stock options exercised in the period. During the year ended February 28, 2023, the Company recorded the following common stock transactions: (i) The Company issued 81,168 shares of the common stock to settle restricted stock units that vested in the period. 16. Research and Development Expenses Research and development expenses for the years ended February 29, 2024 and February 28, 2023 were as follows: February 29, 2024 February 28, 2023 Employee compensation $ 5,133 $ 7,805 Machinery and equipment expenditures 1,142 4,216 External engineering 2,353 3,273 Plant and laboratory operating expenses (1) 2,318 2,581 Tax credits ( 318 ) ( 1,199 ) Other 751 670 $ 11,379 $ 17,346 (1) The amount for the year ended February 29, 2024 includes an inventory write-down of $ 817 (2023 – nil) on finished goods and work in process inventories related to inventory volumes not expected to be sold in the next twelve months (Note 4). 17. General and Administrative Expenses General and administrative expenses for the years ended February 29, 2024 and February 28, 2023 were as follows: February 29, 2024 February 28, 2023 Employee compensation (1) $ 3,223 $ 11,224 Professional fees 2,928 4,288 Insurance 2,680 3,594 Other 1,157 1,323 $ 9,988 $ 20,429 F-21 Table of Contents (1) Includes stock-based compensation expense. During the year ended February 28, 2023, the Company recorded a stock-based compensation expense of $ 7,740 related to the achievement of a performance milestone for 1,000,000 RSUs (Note 14). 18. Share-Based Payments Stock Options The following tables summarizes the continuity of the Company’s stock options during the years ended February 29, 2024 and February 28, 2023: 2024 2023 Number of stock options Weighted average exercise price Number of stock options Weighted average exercise price Outstanding, beginning of year 2,542,000 $ 5.27 1,570,000 $ 6.87 Granted 240,000 3.11 972,000 2.68 Exercised ( 10,000 ) 0.80 - - Forfeited - - - - Expired - - - - Outstanding, end of year 2,772,000 $ 5.10 2,542,000 $ 5.27 Exercisable, end of year 1,810,000 $ 6.53 1,670,000 $ 6.84 2024 2023 Exercise price Number of stock options outstanding Weighted average remaining life (years) Number of stock options outstanding Weighted average remaining life (years) $ 0.80 480,000 1.75 490,000 2.75 $ 2.68 972,000 8.75 972,000 9.75 $ 3.11 240,000 9.08 - - $ 5.25 380,000 3.50 380,000 4.50 $ 12 .00 700,000 3.54 700,000 4.54 Outstanding, end of year 2,772,000 5.53 2,542,000 6.18 Exercisable, end of year 1,810,000 4.55 1,670,000 5.16 The Company applies the fair value method of accounting for stock-based compensation awards granted. Fair value is calculated based on a Black-Scholes option pricing model. The principal components of the pricing model for the stock options granted in the years ended February 29, 2024 and February 28, 2023 were as follows: 2024 2023 Exercise price $ 3.11 $ 2.68 Risk-free interest rate 3.61 % 3.88 % Expected dividend yield 0 % 0 % Expected volatility 73 % 73 % Expected life 6.5 years 5 years During the year ended February 29, 2024, stock-based compensation expense attributable to stock options amounted to $ 644 (2023 – $ 1,316 ). F-22 Table of Contents Restricted Stock Units The following table summarizes the continuity of the restricted stock units (“RSUs”) during the years February 29, 2024 and February 28, 2023: 2024 2023 Number of units Weighted average fair value price Number of units Weighted average fair value price Outstanding, beginning of year 3,888,618 $ 7.09 4,018,567 $ 7.42 Granted 585,364 2.93 151,605 5.14 Settled ( 51,963 ) 8.66 ( 81,168 ) 11.72 Forfeited ( 53,122 ) 5.56 ( 200,386 ) 10.34 Outstanding, end of year 4,368,897 $ 6.53 3,888,618 $ 7.09 Outstanding vested, end of year 1,635,241 $ 6.22 1,563,497 $ 6.29 The Company applies the fair value method of accounting for awards granted through the issuance of restricted stock units. Fair value is calculated based on the intrinsic value at grant date multiplied by the number of restricted stock unit awards granted. During the year ended February 29, 2024, stock-based compensation attributable to RSUs amounted to $ 778 (2023 - $ 8,770 ). During the year ended February 28, 2023, the Company recorded a stock-based compensation expense of $ 7,740 related to the achievement of a performance milestone for 1,000,000 RSUs. Stock-Based Compensation Expense During the year ended February 29, 2024, stock-based compensation included in research and development expenses amounted to $ 542 (2023 – $ 1,337 ), and in general and administrative expenses amounted to $ 880 (2023 – $ 8,749 ). The amount recorded in general and administrative expenses for the year ended February 28, 2023 includes $ 7,740 related to the achievement of a performance milestone for 1,000,000 RSUs. 19. Equity Incentive Plan On July 6, 2017, the Company adopted the Plan. The Plan permits the granting of warrants, stock options, stock appreciation rights and restricted stock units to employees, directors and consultants of the Company. A total of 3,000,000 shares of common stock were initially reserved for issuance under the Plan at July 6, 2017, with annual automatic share reserve increases, as defined in the Plan, amounting to the lessor of (i) 1,500,000 shares, (ii) 5 % of the outstanding shares on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator of the Plan, effective March 1, 2018. On March 1, 2023, the share reserve was increased by 1,500,000 shares. On March 1, 2022, the Board of Directors opted to waive the annual share reserve increase. The Plan is administered by the Board of Directors who designates eligible participants to be included under the Plan, the number of awards granted, the share price pursuant to the awards and the vesting conditions and period. The awards, when granted, will have an exercise price of no less than the estimated fair value of shares at the date of grant and a life not exceeding 10 years from the grant date. However, where a participant, at the time of the grant, owns stock representing more than 10 % of the voting power of the Company, the life of the options shall not exceed 5 years. The following table summarizes the continuity of the Company’s Equity Incentive Plan units that were authorized for issuance as at and during the years ended February 29, 2024 and February 28, 2023: 2024 2023 Number of units* Number of units* Authorized, beginning of period 120,486 1,043,705 Automatic share reserve increase 1,500,000 - Units granted ( 825,364 ) ( 1,123,605 ) Units forfeited 53,122 200,386 Units expired - - Authorized, end of period 848,244 120,486 *The use of the term “units” in the table above describes a combination of stock options and RSUs. F-23 Table of Contents 20. Warrants The following table summarizes the continuity of warrants during the years ended February 29, 2024 and February 28, 2023: 2024 2023 Number of warrants Weighted average exercise price Number of warrants Weighted average exercise price Outstanding, beginning of year 7,089,400 $ 16.65 11,659,418 $ 14.44 Issued - - - - Exercised - - - - Expired - - ( 4,570,018 ) 11.00 Outstanding, end of year 7,089,400 $ 16.65 7,089,400 $ 16.65 The expiration dates of the warrants outstanding as at February 29, 2024 are as follows: Number of warrants Weighted average exercise price July 29, 2024 4,714,813 $ 15.00 (1) 2,357,407 20.00 August 26, 2024 17,180 11.00 Outstanding, end of year 7,089,400 $ 16.65 (1) Warrant granted to SK Geo Centric, Ltd. (“SKGC”) pursuant to the securities purchase agreement entered into by the Company and SKGC on June 22, 2021: Expiration date is the earlier of (A) the date that is the third anniversary of the start of construction of the JV’s first facility, (B) 18 months after the date both parties have approved the basic design package to be used for the JV facilities, provided that the agreements to form the JV have not been executed by that date, and (C) the third anniversary of the date that both parties approved the basic design package to be used for the JV facilities, provided that the start of construction of the JV’s first facility has not occurred as of such date. 21. Interest and Other Financial Expenses Interest and other finance costs for the years ended February 29, 2024 and February 28, 2023 are as follows: 2024 2023 Interest on long-term debt (Note 13) $ 84 $ 86 Accretion expense (Notes 11 and 13) 79 70 Discount on due to customer (Note 11) ( 238 ) - Other 34 33 $ ( 41 ) $ 189 22. Income Taxes The components of the Company’s loss before taxes are summarized below: February 29, 2024 February 28, 2023 U.S. operations $ ( 6,012 ) $ ( 8,406 ) Foreign operations ( 15,075 ) ( 12,895 ) Loss before taxes $ ( 21,087 ) $ ( 21,301 ) F-24 Table of Contents A reconciliation from the statutory U.S. income tax rate and the Company’s effective income tax rate, as computed on loss before taxes, is as follows: February 29, 2024 February 28, 2023 Statutory Federal rate 21 % 21 % Federal income tax at statutory rate $ ( 4,427 ) $ ( 4,473 ) Effect of foreign jurisdiction (937 ) ( 740 ) Non-deductible expenses 1,435 762 Tax credits related to research and development expenditures ( 367 ) ( 202 ) Unrecognized tax benefit of net operating losses and other available deductions 4,296 4,653 Effective income tax expense $ - $ - Current $ - $ - Deferred $ - $ - The Company has net operating loss carry forwards of approximately $ 37,472 (2023 – $ 38,122 ) for U.S. Federal income tax purposes expiring between 2035 and 2038 , post 2018 net operating losses may be carried forward indefinitely. The Company has net operating loss carry forwards for Canadian Federal and Québec tax purposes of approximately $ 83,073 (CDN$112,797), 2023 – $ 67,617 (CDN$92,020), and $ 89,532 (CDN$121,572), 2023 – $ 70,747 (CDN$96,279), respectively, expiring between 2037 and 2044. Realization of future tax assets is dependent on future earnings, the timing and amount of which are uncertain. Accordingly, the net future tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $ 4,905 and $ 4,347 , respectively, for the years ended February 29, 2024 and February 28, 2023. The Company has provided a full valuation allowance on the deferred tax assets as a result of the uncertainty regarding the probability of its realization. The Company has approximately $ 9,506 (CDN$12,903), 2023 - $ 7,471 (CDN$10,168) of research and development expenditures for Canadian Federal and Québec provincial purposes that are available to reduce taxable income in future years and have an unlimited carry forward period, the benefit of which has not been reflected in these financial statements. Research and development expenditures are subject to audit by the taxation authorities and accordingly, these amounts may vary. The tax effect of temporary differences between US GAAP accounting and federal income tax accounting creating deferred income tax assets and liabilities were as follows: As at February 29, 2024 February 28, 2023 Deferred tax assets Canada net operating loss carry forward $ 22,765 $ 18,278 U.S. net operating loss carry forward 7,869 8,006 Accrual and reserves 616 546 Intangibles 304 214 Property, plant and equipment 1,914 2,253 Research and development expenditures and credits 4,428 3,569 Basis in partnership 235 235 Other 859 895 Deferred tax assets 38,990 33,996 Deferred tax liabilities Intangibles ( 409 ) ( 320 ) Other - - Deferred tax liabilities ( 409 ) ( 320 ) Deferred tax assets, net 38,581 33,676 Valuation allowance ( 38,581 ) ( 33,676 ) Deferred tax assets, net $ - $ - F-25 Table of Contents Assessment of the amount of value assigned to the Company's deferred tax assets under the applicable accounting rules is judgmental. The Company is required to consider all available positive and negative evidence in evaluating the likelihood that the Company will be able to realize the benefit of its deferred tax assets in the future. Such evidence includes scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and the results of recent operations. Since this evaluation requires consideration of events that may occur some years into the future, there is an element of judgment involved. Realization of the Company's deferred tax assets is dependent on generating sufficient taxable income in future periods. Management does not believe that it is more likely than not that future taxable income will be sufficient to allow it to recover substantially all of the value assigned to its deferred tax assets. Accordingly, the Company has provided for a valuation allowance of the Company's deferred tax assets. The tax years subject to examination by major tax jurisdiction include the years ended February 28, 2019 and forward by the U.S. Internal Revenue Service and most state jurisdictions, and the years ended February 28, 2019 and forward for the Canadian jurisdiction. 23. Legal Settlement On October 13, 2020, the Company and certain of its officers were named as defendants in a proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Olivier Tremblay, Individually and on Behalf of All Others Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti , Case No. 7:20-cv-08538-NSR (“Tremblay Class Action”). The complaint alleged that the defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The complaint sought unspecified damages on behalf of a class of purchasers of Loop’s securities between September 24, 2018 and October 12, 2020, inclusive. On October 28, 2020, the Company and certain of its officers were named as defendants in a second proposed class-action lawsuit filed in the United States District Court for the Southern District of New York, captioned Michelle Bazzini, Individually and on Behalf of All Others Similarly Situated v. Loop Industries, Inc., Daniel Solomita, and Nelson Gentiletti , Case No. 7:20-cv-09031-NSR. The complaint allegations were similar in nature to those in the Tremblay Class Action. On January 4, 2021, the United States District Court for the Southern District of New York consolidated the two proposed class-action lawsuits as In re Loop Industries, Inc. Securities Litigation , Master File No. 7:20-cv-08538-NSR. Sakari Johansson and John Jay Cappa were appointed as Co-Lead Plaintiffs and Glancy Prongay & Murray LLP and Pomerantz LLP were appointed as Co-Lead Counsel for the class. Plaintiffs served a consolidated amended complaint on February 18, 2021, which alleged that the defendants violated Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 by allegedly making materially false and/or misleading statements, as well as allegedly failing to disclose material adverse facts about the Company’s business, operations, and prospects, which caused the Company’s securities to trade at artificially inflated prices. The consolidated amended complaint relied on the October 13, 2020 report published by a third party regarding the Company to support their allegations. Defendants served a motion to dismiss the consolidated amended complaint on April 27, 2021. Plaintiffs’ opposition to the motion to dismiss was served on May 27, 2021 and Defendants’ reply in support of the motion to dismiss was served on June 11, 2021. On March 1, 2022, the Company and the current and former officer defendants entered into an agreement for the settlement of In re Loop Industries, Inc. Securities Litigation, and, on March 4, 2022, advised the Court of the agreement to settle. The agreement, which was subject to certain conditions, including court approval, required the Company to pay $ 3.1 million to the plaintiff class. As a result, the Company recorded a contingency loss of $ 2,519 which was included in accounts payable and accrued liabilities at February 28, 2022 and expected to be the Company’s approximate total cash contribution to the settlement and outstanding legal fees related to the lawsuit, net of the Company’s D&O insurance carriers’ contribution. On May 24, 2022, Lead Plaintiffs filed their motion for preliminary approval of the proposed class action settlement. On September 19, 2022, the Court entered an order preliminarily approving the settlement and providing for notice. The Court held a final settlement hearing on January 5, 2023 after which the Court entered an order and final judgment approving the class action settlement. In October 2022, the Company made a payment in escrow of $3,100 for the settlement and received $ 838 from its D&O insurance carriers. As at February 29, 2024, the Company no longer has any amount related to the class action settlement included in accounts payable and accrued liabilities. F-26 Table of Contents The settlement agreement does not constitute an admission, concession, or finding of any fault, liability, or wrongdoing by the Company or any defendant. 24. Contractual agreement Agreement with SKGC On April 27, 2023, the Company and SKGC entered into an agreement to build Infinite Loop ™ manufacturing facilities in Asia. Pursuant to the agreement, the Company and SKGC agreed to form a new entity, which will be headquartered in Singapore. To date, no amounts have been contributed by the Company to the new entity. 25. Subsequent Events Strategic partnership with Ester Industries Ltd. (“Ester”) On May 1, 2024, Loop entered into an agreement with Ester, a manufacturer of polyester films and specialty polymers in India, to form a 50/50 joint venture based in India ("India JV"). The purpose of the India JV is to build and operate an Infinite Loop ™ manufacturing facility in India which will produce lower carbon footprint rDMT, rMEG and specialty polymers, using the Infinite Loop ™ Technology. Subject to the terms of the relevant governing documents, Ester will be the exclusive producer of specialty polymers for the India JV, and Loop will be the exclusive seller and marketing agent of the India JV’s products. Ester and Loop will work in collaboration on all financing activities for the India JV pursuant to the terms of the Agreement and will each contribute 50% of the initial equity capital of the India JV . F-27 Table of Contents ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE None.